Page 2 of articles about swine-diseases in Press releases

The recent discovery of Aujeszky’s Disease in pigs in the Pyrenees Atlantic region of France reminds us that we cannot take the absence of notifiable diseases for granted.

EXCEDE® is now approved by the U.S. Center for Veterinary Medicine and the Food and Drug Administration for the control of swine respiratory disease (SRD) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Haemophilus parasuis and Streptococcus suis in groups of pigs where SRD has been diagnosed.

The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo®.

With the launch of Ingelvac CircoFLEX® by Boehringer Ingelheim on the Russian market, pig producers in Russia now have access to the world’s market leading vaccine against porcine Circovirus type 2 (PCV2).

Worms can still be a cause of financial loss in pigs. The main species of concern are ascarids (roundworms) which, in the course of the migration through the body, damage lungs and cause coughing.

H1N2, H1N1 and H3N2 are the three influenza A virus subtypes of the Swine Influenza virus contained in GRIPOVAC®3, a new vaccine against swine influenza.

IDT Biologika has developed and is marketing the first swine influenza vaccine - Respiporc Flu3 - registered for protection against the three most clinically significant subtypes of the virus, H1N1, H3N2 and H1N2.

The American Association of Swine Veterinarians is pleased to announce the publication of the 4th edition of the Swine Disease Manual, edited by Drs. Eric Neumann, Alex Ramirez, and Kent Schwartz.

Despite years of hard work by scientists, researchers, practicing veterinarians, pork producers, animal health companies, and others, Porcine Reproductive and Respiratory Syndrome (PRRS) remains a costly, frustrating challenge to the global swine industry.

Diseases associated with PCV2 infection (PCVD) belong to the most devastating diseases in swine worldwide. Fortunately, since a few years, losses attributed to this disease complex can be controlled very effectively by vaccinating piglets.

A new disease which poses as great a risk as foot-and-mouth disease could devastate the British pig industry unless controls are tightened up.

The H1N1 virus has now been found in a Canadian swine herd, and an Iowa State University researcher is ready to produce an H1N1 flu vaccine for pigs.

PRRS X3 test delivers 99.9% specificity and 90% reduction of false positives

Hypor B.V. announced today that recently acquired France-Hybrides has successfully shipped 315 GGP females and boars from their Sichamps and Châteauneuf-sur-Loire French nucleus farms to pig farms located in Shandong Province. This shipment was organized by the Shandong Husbandry Bureau.

Novartis Animal Health announced today the expansion of its U.S. swine sales team – increasing its total number of U.S. swine sales, marketing and technical service professionals to 20

Despite years of hard work by scientists, researchers, practicing veterinarians, pork producers, animal health companies, and others, Porcine Reproductive and Respiratory Syndrome (PRRS) remains a costly, frustrating challenge to the global swine industry. At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts for PRRS control. Each year we issue a call for proposals for the Annual Boehringer Ingelheim Advancement in PRRS Research Award Program. The deadline for submissions are January 1 of each year